 |
| Risk-based Monitoring White Paper |
A number of factors are leading to the paradigm shift in the way that clinical research is conducted. The increasing cost of research and the adoption of EDC technologies that provide real-time access to data have forced the industry to look at optimized methods of conducting clinical studies. In addition, several studies have shown that 100% SDV may not result in higher data quality. All of these factors have led to increased interest in RBM strategies.
Download white paper
Risk-Based Monitoring for Late-Phase Research
Download Related Podcast
Risk-Based Monitoring for Late Phase: Implementation Strategies
Download Podcast Transcript
See All PharmaVOICE White Papers
See All PharmaVOICE Podcasts
Posts
